Literature DB >> 23543529

WITHDRAWN: Patient controlled intravenous opioid analgesia versus continuous epidural analgesia for pain after intra-abdominal surgery.

Thewarug Werawatganon1, Somrat Charuluxananan.   

Abstract

BACKGROUND: There are two common techniques for postoperative pain control after intra-abdominal surgery: patient-controlled analgesia (PCA) with intravenous opioids and continuous epidural analgesia (CEA). It is uncertain which method has better pain control and fewer adverse effects.
OBJECTIVES: The objective of this review was to compare PCA opioid therapy with CEA for pain control after intra-abdominal surgery in terms of analgesic efficacy, side effects, patient satisfaction and surgical outcome by meta-analysis of the relevant trials. SEARCH
METHODS: We searched CENTRAL (The Cochrane Library Issue 4, 2002), MEDLINE (January 1966 to October 2002), EMBASE (January 1988 to October 2002), and reference lists of articles. We also contacted researchers in the field. SELECTION CRITERIA: Randomized controlled trials of adult patients after intra-abdominal surgery comparing the effect of two pain control regimens in terms of analgesic efficacy and side effects. In the patient-controlled analgesia (PCA) group the patient should be able to operate the device himself. In the continuous epidural analgesia group there was no PCA device. DATA COLLECTION AND ANALYSIS: Two authors independently assessed trial quality and extracted data. Study authors were contacted for additional information. Adverse effects information was collected from the trials. MAIN
RESULTS: Nine studies involving 711 participants were included. The PCA group had a higher pain visual analogue scale than the CEA group during 6, 24 and 72 hour periods. The weighted mean difference and 95% confidence interval of resting pain was 1.74 (95% CI 1.30 to 2.19), 0.99 (95% CI 0.65 to 1.33), and 0.63 (95% CI 0.24 to 1.01), respectively. The length of hospital stay and other adverse effects were not statistically different except that the incidence of pruritus was lower in the PCA group, odds ratio of 0.27 (95% CI 0.11 to 0.64). AUTHORS'
CONCLUSIONS: CEA is superior to opioid PCA in relieving postoperative pain for up to 72 hours in patients undergoing intra-abdominal surgery, but it is associated with a higher incidence of pruritus. There is insufficient evidence to draw comparisons about the other advantages and disadvantages of these two methods of pain relief.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23543529     DOI: 10.1002/14651858.CD004088.pub3

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  5 in total

1.  A Clinical Comparison of Intravenous and Epidural Local Anesthetic for Major Abdominal Surgery.

Authors:  Abdullah S Terkawi; Siny Tsang; Ali Kazemi; Steve Morton; Roy Luo; Daniel T Sanders; Lindsay A Regali; Heather Columbano; Nicole Y Kurtzeborn; Marcel E Durieux
Journal:  Reg Anesth Pain Med       Date:  2016 Jan-Feb       Impact factor: 6.288

2.  Epidural analgesia versus patient-controlled intravenous analgesia for pain following intra-abdominal surgery in adults.

Authors:  Jon H Salicath; Emily Cy Yeoh; Michael H Bennett
Journal:  Cochrane Database Syst Rev       Date:  2018-08-30

3.  Efficacy of intrathecal morphine combined with intravenous analgesia versus thoracic epidural analgesia after gastrectomy.

Authors:  Jae Hoon Lee; Jin Ha Park; Hae Keum Kil; Seung Ho Choi; Sung Hoon Noh; Bon-Nyeo Koo
Journal:  Yonsei Med J       Date:  2014-07       Impact factor: 2.759

4.  Thoracic Epidural analgesia versus Rectus Sheath Catheters for open midline incisions in major abdominal surgery within an enhanced recovery programme (TERSC): study protocol for a randomised controlled trial.

Authors:  Kate M Wilkinson; Anton Krige; Sarah G Brearley; Steven Lane; Michael Scott; Anthony C Gordon; Gordon L Carlson
Journal:  Trials       Date:  2014-10-21       Impact factor: 2.279

5.  Continuous wound infiltration or epidural analgesia for pain prevention after hepato-pancreato-biliary surgery within an enhanced recovery program (POP-UP trial): study protocol for a randomized controlled trial.

Authors:  Timothy H Mungroop; Denise P Veelo; Olivier R Busch; Susan van Dieren; Thomas M van Gulik; Tom M Karsten; Steve M de Castro; Marc B Godfried; Bram Thiel; Markus W Hollmann; Philipp Lirk; Marc G Besselink
Journal:  Trials       Date:  2015-12-09       Impact factor: 2.279

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.